RecruitingNCT01776905

In Vivo Real-time Detection of Circulating Melanoma Cells

Sponsor

University of Arkansas

Enrollment

75 participants

Start Date

Feb 1, 2013

Study Type

OBSERVATIONAL

Conditions

Melanoma

Summary

The objective of this clinical trial is to determine whether a Photoacoustic flow cytometry (PAFC)-based prototype device can detect circulating tumor cells (CTCs) in the blood of melanoma patients in vivo, in real time, and do so at detection limits at least one order of magnitude below the detection limits of currently existing ex vivo methods.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

Age 18 to 80 years
Histological documented diagnosis of melanoma
Signed informed consent form approved by the University of Arkansas for Medical Sciences (UAMS) Institutional Review Board (IRB)
Must be able to sit still for 90 minutes

Exclusion Criteria4

Active infection
Current and significant medical or surgical condition as determined by the Investigator
Diagnosis or evidence of organic brain syndrome
Pregnancy or breastfeeding